
Loading, please wait...

Loading, please wait...

Researchers recently explored how Boswellia dalzielii brain enzymes modulation could pave the way for new neuroprotective therapies. Traditional African medicine has long utilized Boswellia dalzielii to manage cognitive and neurological issues. However, the scientific basis for these effects required rigorous in vitro validation. A recent study published in BMC Complementary Medicine and Therapies investigated how different plant parts affect enzymes crucial for maintaining cognitive health.
The study found that the stem bark extract was the most potent inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). These enzymes break down acetylcholine, a neurotransmitter vital for memory. By inhibiting these enzymes, the extract may help maintain higher acetylcholine levels. Consequently, this mechanism mirrors the action of standard dementia medications. Additionally, the root bark extract showed the strongest inhibition of monoamine oxidase (MAO), which is a key target in managing depression and Parkinson's disease.
Furthermore, the extracts influenced other enzymatic pathways. They inhibited ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) and ecto-5'-nucleotidase. These enzymes regulate purinergic signaling, which plays a role in neuroinflammation and cellular energy balance. The stem bark extract also moderately enhanced Na⁺/K⁺-ATPase activity. This modulation helps maintain the ionic gradients necessary for proper neuronal firing. Overall, the presence of stilbenoids across all plant parts likely contributes to these multi-target effects.
While these results are preliminary, they provide a strong foundation for future research. Specifically, the stem bark's potency suggests it could be a primary candidate for isolating bioactive compounds. The multi-enzyme inhibitory profile indicates that Boswellia dalzielii might offer a holistic approach to complex brain disorders. Future in vivo studies are necessary to confirm if these laboratory findings translate into clinical benefits for patients with Alzheimer's or other cognitive impairments.
According to the study, the stem bark extract demonstrated the most potent inhibition of enzymes related to memory and neuronal function, followed by the root and leaf extracts.
The stem bark extract showed inhibitory potency against cholinesterase enzymes that was comparable to Prostigmine, a standard pharmaceutical inhibitor, in laboratory settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study finds that Boswellia dalzielii extracts, particularly the stem bark, inhibit key enzymes like AChE and MAO, suggesting potential neuroprotective use...
5 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today